A District of Massachusetts judge has certified two multi-jurisdictional classes, one of third-party payors and another for consumers paying for physician administered drugs, alleging that AstraZeneca and Bristol-Meyers inflated wholesale drug prices. Judge Patti Saris rejected the defendants’ objection that the 39 differing state laws at issue would render class action treatment unmanageable.